Viewing Study NCT01822951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-03 @ 8:25 AM
Study NCT ID: NCT01822951
Status: WITHDRAWN
Last Update Posted: 2015-10-26
First Post: 2013-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Sponsor: Ever Neuro Pharma GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DAT Study View